ClinicalTrials.gg
Biological

BNT162 Vaccine clinical trials

Also written BNT162b2 and Tozinameran.

studies test it
58
open now
5
in phase 3
23
first study started
2020

How each study uses BNT162 Vaccine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the BNT162 Vaccine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Comirnaty
13
BNT162b2 vaccine
5
Pfizer-BioNTech COVID-19 Vaccine
3
BNT162b2 (Omi XBB.1.5)
2
Tozinameran - Fractional Dose
2

Development codes

BNT162b2
29
BNT162c2
1

Other names

Tozinameran
6
BNT162b1
3
Pfizer Covid-19 vaccine
2
BNT162a1
1

Studies by the year they started

58 studies that test it; most in 2021 (32)

Studies that test BNT162 Vaccine, by start year
YearStudies
20205
202132
20229
20232
20243
20254
20263

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
26
Phase 3
23
Phase 4
13

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 23 · Other 35

BioNTech SE (20) · Murdoch Childrens Research Institute (5) · National Institute of Allergy and Infectious Diseases (NIAID) (4) · The University of Hong Kong (3) · Pfizer (2) · Assistance Publique - Hôpitaux de Paris (2) · Sheba Medical Center (1) · University of Michigan (1)

Often tested with

Tested in the same studies.

2019-nCoV Vaccine mRNA-1273 (12) · ChAdOx1 nCoV-19 (5) · Sinovac COVID-19 vaccine (4) · Ad26COVS1 (3) · Biological Products (1) · AS03 (1) · Pneumococcal 20-Valent Conjugate Vaccine (1) · SARS-CoV-2 mRNA Vaccine ARCT-021 (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test BNT162 Vaccine, phase 3 first.

Studies

Open first, then newest update. How each study uses BNT162 Vaccine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 58

See all 58 studies that test BNT162 Vaccine →

Given beside what is tested · 5 — BNT162 Vaccine is usual care or a partner of the new treatment
As the comparator · 23 — what is tested is compared with BNT162 Vaccine

Showing 20 of 23.

Codes

What other systems call BNT162 Vaccine · ClinicalTrials.gg INT006857

  • MeSH (NLM) D000090982BNT162 VaccineConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 5085ZFP6SJTOZINAMERANConfirmed FDA, NLM

Also registered as abdavomeran (UNII JV8KBX6XZG), bnt-162a1 (UNII N38TVC63NU) and pidacmeran (UNII 6FH8H9CL41).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.